Further research is required to fully elucidate WFS1’s role in the cellular pathway, perhaps facilitating the development of new therapeutic strategies for Alzheimer’s disease and sleep disorders. Here, WFS1 is linked to early-onset autosomal dominant Alzheimer disease.